MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0056893
Millifluous Pharmaceuticals Private Limited
Millifluous Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. Directors, charges & compliance details.
Revenue · FY 2024
₹4.56 Lakh
Latest filing
Net loss · FY 2024
₹2.03 Lakh
Net margin -44.6%
EBITDA · FY 2024
-₹1.86 Lakh
EBITDA margin -40.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹8 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Millifluous Pharmaceuticals Private Limited
Data last updated:
Millifluous Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 10 January 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2023PTC409777.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors including Shipra Das and Rimpa Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 55 2nd Floor Lane 2 Westend Marg Saidullajab, Near Saket Metro Station, New Delhi, Delhi, India – 110030.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.56 Lakh. For the same year it recorded a net loss of ₹2.03 Lakh (net margin -44.6%) and EBITDA of -₹1.86 Lakh (EBITDA margin -40.7%).
Millifluous Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0056893).
Company details
CIN U51909DL2023PTC409777
Registration Number 409777
Incorporation Date 10 January 2023
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0056893
Recognitions & Rankings of Millifluous Pharmaceuticals
Contact details
Millifluous Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressH. No. 55 2nd Floor Lane 2 Westend Marg Saidullajab, Near Saket Metro Station, New Delhi, Delhi, India – 110030
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Millifluous Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Millifluous Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Millifluous Pharmaceuticals Private Limited, buy the company report.
Financials of Millifluous Pharmaceuticals Private Limited
FY 2025 filings availableMillifluous Pharmaceuticals Private Limited reported revenue of ₹4.56 Lakh for FY 2024.
Revenue · FY 2024
₹4.56 Lakh
Net loss · FY 2024
₹2.03 Lakh margin -44.6%
EBITDA · FY 2024
-₹1.86 Lakh margin -40.7%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.86 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹2.03 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -40.7% | |
| Net Profit Margin | -44.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Millifluous Pharmaceuticals Private Limited, buy the company report.
Board of directors of Millifluous Pharmaceuticals Private Limited
Millifluous Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shipra Das | Director | 10 Jan 2023 | 3 Years 9 Months | Current |
| Rimpa Das | Director | 10 Jan 2023 | 3 Years 9 Months | Current |
| Sampita Biswas Also directs: Odb Realty Private Limited | Director | 10 Jan 2023 | 3 Years 9 Months | Current |
| Snigdha Dey Dutta | Director | 03 Mar 2025 | 1 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Millifluous Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Millifluous Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Millifluous Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Millifluous Pharmaceuticals Private Limited has 5 board changes on record since 2023: 4 appointments and 1 cessation. The latest: Chandra Das ceased to be Director on 04 Mar 2025.
AGM
Millifluous Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Millifluous Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Chandra Das ceased to be Director.
Appointed
Snigdha Dey Dutta was appointed as Director.
Appointed
Rimpa Das was appointed as Director.
Appointed
Sampita Biswas was appointed as Director.
Appointed
Shipra Das was appointed as Director.
Incorporation
10 Jan 2023
Millifluous Pharmaceuticals Private Limited was registered on 10 Jan 2023 with Roc Delhi I & aged 3 years 9 months as per MCA records.
Frequently asked questions
Millifluous Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 10 January 2023 (3+ years old) and is registered under CIN U51909DL2023PTC409777.
Millifluous Pharmaceuticals has 4 current directors:
- Shipra Das - Director
- Rimpa Das - Director
- Sampita Biswas - Director
- Snigdha Dey Dutta - Director
The latest financial statements of Millifluous Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Millifluous Pharmaceuticals is U51909DL2023PTC409777. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Millifluous Pharmaceuticals was incorporated on 10 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Chandra Das ceased to be Director on 04 Mar 2025. Snigdha Dey Dutta was appointed as Director on 03 Mar 2025. Rimpa Das was appointed as Director on 10 Jan 2023. Millifluous Pharmaceuticals has 5 board changes on record in total.
Yes, Millifluous Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0056893).
The registered office of Millifluous Pharmaceuticals is at H. No. 55 2nd Floor Lane 2 Westend Marg Saidullajab, Near Saket Metro Station, New Delhi, Delhi, India – 110030.
Millifluous Pharmaceuticals operates in the trading industry, in the specialty segment.
Millifluous Pharmaceuticals can be reached at its registered office: H. No. 55 2nd Floor Lane 2 Westend Marg Saidullajab, Near Saket Metro Station, New Delhi, Delhi, India – 110030.